Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4151

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-4151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text provides information about Venlafaxine HCI Extended Release capsules of 75 mg strength, with a quantity of 30 capsules. It includes the NDC number, manufacturing details, storage instructions, and contact information for a repackaging company. It also mentions the need to keep the medication out of the reach of children and refers to the package insert for directions.*

FDA Label Image

Image-01 (Image 01)

FDA Label Image

Image-02 (Image 02)

This is a list related to the evaluation of a special population with Hepatic and Renal impairments, as well as considerations for CYP2D6 polymorphism, age, and gender effects. It includes specific analytes such as venlafaxine and their variations in different conditions. Additionally, it mentions PK values, fold change, and relative changes compared to reference values. The text indicates a focus on pharmacokinetics and drug metabolism in individuals with specific health conditions and characteristics.*

FDA Label Image

Image-03 (Image 03)

This is a pharmaceutical evaluation of the impact of interacting drugs on the Pharmacokinetic (PK) parameters of the analyte Venlafaxine. The data includes the fold change and 90% Confidence Interval (CI) for various drug combinations such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. Information about changes in Cmax (maximum concentration) and AUC (area under the curve) are provided. The evaluation is done based on the comparison to a reference value.*

FDA Label Image

Image-04 (Image 04)

This is a list of interacting drugs and their analytes, which include medications like diazepam, alprazolam, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, lithium, and ethanol. The document also mentions the active moieties of these drugs and provides information on fold change and 90% confidence intervals for the interactions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.